Literature DB >> 24094688

Investigation of the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.

John H Pigott1, Akikazu Ishihara, Maxey L Wellman, Duncan S Russell, Alicia L Bertone.   

Abstract

Mesenchymal stem cells have demonstrated immunomodulatory capabilities as well as modest efficacy in animal models of joint injury, warranting further study as a potential treatment of joint disease. The goal of the study was to investigate the blood and synovial immune and histologic response to intra-articular injection of autologous, allogeneic, and xenogeneic bone marrow-derived mesenchymal stem cells (MSC) in horses. The study group consisted of 6 five-year-old Thoroughbred mares that had been injected previously with 15 million, genetically modified autologous, allogeneic, or xenogeneic MSC into the fetlock joints. One group of autologous cells was genetically modified to permit MSC biolocalization in the synovium. To assess response to the injection, synovial biopsies were obtained via arthroscopy 60 days after MSC injection for gross, histologic and molecular analyses. Peripheral blood mononuclear cells were isolated from each horse 120 days after MSC injection and co-cultured with a monolayer of each MSC group to permit quantification of activated CD4+ lymphocytes and cytokine release (ELISA) upon re-exposure to MSC. Arthroscopic examination revealed normal synovium with no grossly detrimental effect to the synovium or cartilage. Intra-articular MSC produced a persistent mononuclear infiltrate for at least 60 days, mostly perivascular, identified as CD3+ lymphocytes. An immune response (significant increase in CD4+ lymphocytes) was detected upon re-exposure to xenogeneic but not to allogeneic or autologous MSC. An inflammatory cytokine release from peripheral blood mononuclear cell/MSC co-cultures was present in all MSC groups but was significantly greater in the xenogeneic group. In conclusion, intra-articular injection of MSC, regardless of cell origin, incited a persistent mononuclear synovitis demonstrating a sustained biologic influence of these cells. Allogeneic cells did not elicit a detectable immune response upon re-exposure using our methods.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Allo; Allogeneic; Auto; Auto-BMP2; Autologous; BMDMSC; BMP2; Horse; Immune; Intra-articular; MSC; Stem cell; Xeno; allogeneic mesenchymal stem cells; autologous mesenchymal stem cells; autologous mesenchymal stem cells genetically modified to secrete human bone morphogenetic protein 2; bone marrow-derived mesenchymal stem cells; bone morphogenetic protein 2; mesenchymal stem cells; xenogeneic mesenchymal stem cells

Mesh:

Substances:

Year:  2013        PMID: 24094688     DOI: 10.1016/j.vetimm.2013.09.003

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  28 in total

Review 1.  Factors governing the immunosuppressive effects of multipotent mesenchymal stromal cells in vitro.

Authors:  Aleksandra Gornostaeva; Elena Andreeva; Ludmila Buravkova
Journal:  Cytotechnology       Date:  2015-08-13       Impact factor: 2.058

2.  Persistence of fluorescent nanoparticle-labelled bone marrow mesenchymal stem cells in vitro and after intra-articular injection.

Authors:  Sicilia T Grady; Lorraine Britton; Katrin Hinrichs; Alan J Nixon; Ashlee E Watts
Journal:  J Tissue Eng Regen Med       Date:  2019-01-23       Impact factor: 3.963

3.  Programmable microencapsulation for enhanced mesenchymal stem cell persistence and immunomodulation.

Authors:  Angelo S Mao; Berna Özkale; Nisarg J Shah; Kyle H Vining; Tiphaine Descombes; Liyuan Zhang; Christina M Tringides; Sing-Wan Wong; Jae-Won Shin; David T Scadden; David A Weitz; David J Mooney
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-16       Impact factor: 11.205

Review 4.  The Challenge in Using Mesenchymal Stromal Cells for Recellularization of Decellularized Cartilage.

Authors:  Zhao Huang; Owen Godkin; Gundula Schulze-Tanzil
Journal:  Stem Cell Rev Rep       Date:  2017-02       Impact factor: 5.739

Review 5.  Treating childhood traumatic brain injury with autologous stem cell therapy.

Authors:  Shyam Dewan; Samantha Schimmel; Cesar V Borlongan
Journal:  Expert Opin Biol Ther       Date:  2018-02-15       Impact factor: 4.388

Review 6.  Endogenous repair theory enriches construction strategies for orthopaedic biomaterials: a narrative review.

Authors:  Yizhong Peng; Jinye Li; Hui Lin; Shuo Tian; Sheng Liu; Feifei Pu; Lei Zhao; Kaige Ma; Xiangcheng Qing; Zengwu Shao
Journal:  Biomater Transl       Date:  2021-12-28

7.  Phenotypic and immunomodulatory properties of equine cord blood-derived mesenchymal stromal cells.

Authors:  Laurence Tessier; Dorothee Bienzle; Lynn B Williams; Thomas G Koch
Journal:  PLoS One       Date:  2015-04-22       Impact factor: 3.240

8.  Human Urine-derived Stem Cells Seeded Surface Modified Composite Scaffold Grafts for Bladder Reconstruction in a Rat Model.

Authors:  Jun Nyung Lee; So Young Chun; Hyo-Jung Lee; Yu-Jin Jang; Seock Hwan Choi; Dae Hwan Kim; Se Heang Oh; Phil Hyun Song; Jin Ho Lee; Jong Kun Kim; Tae Gyun Kwon
Journal:  J Korean Med Sci       Date:  2015-11-30       Impact factor: 2.153

9.  Post-thaw non-cultured and post-thaw cultured equine cord blood mesenchymal stromal cells equally suppress lymphocyte proliferation in vitro.

Authors:  Lynn B Williams; Laurence Tessier; Judith B Koenig; Thomas G Koch
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

10.  Single and repeated intra-articular injections in the tarsocrural joint with allogeneic and autologous equine bone marrow-derived mesenchymal stem cells are safe, but did not reduce acute inflammation in an experimental interleukin-1β model of synovitis.

Authors:  Aimée C Colbath; Steven W Dow; Leone S Hopkins; Jennifer N Phillips; C Wayne McIlwraith; Laurie R Goodrich
Journal:  Equine Vet J       Date:  2020-02-14       Impact factor: 2.888

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.